Cyclacel Pharmaceuticals Inc share price logo

Cyclacel Pharmaceuticals Inc Share Price

NASDAQ: CYCC

Small Cap

$6.26

-0.51

(-7.49%)

as on

Cyclacel Pharmaceuticals Inc Stock Performance

as on September 12, 2025 at 1:28 am IST

  • Day's Low

    Day's High

    $6.1
    $6.98
    downward going graph

    2.56%

    Downside

    11.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.08
    $597.6
    downward going graph

    50.80%

    Downside

    9446.33%

    Upside

    downward going graph

Cyclacel Pharmaceuticals Inc share price movements today

Previous Close
$6.77
Open
$6.42
Volume
332.6K
Day's Low - High
$6.1 - $6.98
52 Week Low - High
$3.08 - $597.6

Cyclacel Pharmaceuticals Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Cyclacel Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Cyclacel Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.3M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

0

P/B Ratio

0.0009

PEG Ratio

0

EBITDA

-10.4M

Revenue (TTM)

10.0K

Profit Margin

0.00%

Return On Equity TTM

-276.80%

Cyclacel Pharmaceuticals Inc Stock Valuation

Track how Cyclacel Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Cyclacel Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 12, 2025

Industry (0.00x)

September 12, 2025

Today (0.00x)

September 12, 2025

Highest (0.00x)

September 12, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Cyclacel Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cyclacel Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cyclacel Pharmaceuticals Inc image
Cyclacel Pharmaceuticals Inc
BUY$14.3MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.5B282.7%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.9B54.04%28.2431.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.2B2.03%14.3331.37%

Analyst Recommendation on Cyclacel Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Cyclacel Pharmaceuticals Inc. Average target price of $1

Cyclacel Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Cyclacel Pharmaceuticals Inc.

What analysts predicted

-526%DOWNSIDE

Target Price

$1

Current Price

$6.26

Analyzed by

9 Analysts

Target

$1.00

Cyclacel Pharmaceuticals Inc target price $1, a slight downside of -526% compared to current price of $6.26. According to 9 analysts rating.

Cyclacel Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Cyclacel Pharmaceuticals Inc Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-85% versus previous 30 day period

Cyclacel Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
0
0
0
0
0
0
-
0
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-7
-5
-6
-5
-4
-3
-2
-1
-5
-1
EBITDA
-7
-5
-6
-5
-4
-3
-2
-
-5
-1
Interest Expense
0
-
-
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
-
0
Income Before Tax
-7
-6
-6
-5
-4
-3
-2
-1
0
-1
Income Tax Expense
-1
0
0
0
-1
0
0
-
1
0
Net Income
-5
-5
-6
-5
-2
-3
-1
-3
0
-1
Net Profit Margin
0.00%
-1460.59%
-37700.00%
-17003.23%
-10158.62%
-81425.00%
-19570.00%
0.00%
231.43%
0.00%

Cyclacel Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
0
-
0
-
0
-
0
0
0
Gross Profit
-10
-8
0
-4
0
0
0
0
0
0
Operating Income
-16
-14
-9
-9
-9
-10
-22
-27
-25
-12
EBITDA
-15
-14
-9
-9
-9
-10
-22
-27
-25
-11
Interest Expense
-
-
-
-
0
0
0
2
2
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-16
-13
-8
-8
-9
-9
-22
-25
-25
-11
Income Tax Expense
-2
-1
0
-1
-1
-1
-3
-4
-2
0
Net Income
-14
-11
-7
-7
-7
-8
-18
-21
-22
-11
Net Profit Margin
-737.76%
-1398.70%
0.00%
-4858.67%
0.00%
-143695.76%
0.00%
-5683.11%
-5370.24%
-26074.42%

Cyclacel Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-6
-5
-2
-3
-1
-3
0
0
Operating Cash Flow
-1
-4
-3
0
-3
-3
-1
-3
0
Investing Cash Flow
-
4
-4
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
6
0
1
3
0
Change in Cash
-1
-4
-2
0
3
-3
0
0
0

Cyclacel Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-11
-7
-7
-7
-8
-18
-21
-22
-11
Operating Cash Flow
-10
-7
-6
-9
-7
-18
-20
-16
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
6
14
0
3
29
21
2
0
7
Change in Cash
-3
7
-6
-5
21
3
-18
-14
0

Global Institutional Holdings in Cyclacel Pharmaceuticals Inc

Funds
Holdings
SBI Securities Co Ltd
0%
Financial Gravity Wealth, Inc.
0%
Archer Investment Corporation
0%
SignatureFD, LLC
0%
Point72 Asset Management, L.P.
0%
See all

Insights on Cyclacel Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.8% return, outperforming this stock by 226.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 174.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CYCC stock has moved down by -10.4%

About Cyclacel Pharmaceuticals Inc

cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.
OrganisationCyclacel Pharmaceuticals Inc
HeadquartersLevel 10, Kuala Lumpur, Malaysia, 592000
IndustryHealth Technology
CEODr. Sing Ee Wong
E-voting on sharesClick here to vote

Key Management of Cyclacel Pharmaceuticals Inc

Name

Title

Dr. Sing Ee Wong

Chairman, CEO & President

Mr. Cu Seng Kiu

Executive Director, CFO & Secretary

Ms. Gill Christie

Director of Human Resources

Grace Kim

Investor Relations Executive

FAQs

What is Cyclacel Pharmaceuticals Inc share price today?

Cyclacel Pharmaceuticals Inc share price today is $6.26 as on at the close of the market. Cyclacel Pharmaceuticals Inc share today touched a day high of $6.98 and a low of $6.1.

What is the 52 week high and 52 week low for Cyclacel Pharmaceuticals Inc share?

Cyclacel Pharmaceuticals Inc share touched a 52 week high of $597.6 on and a 52 week low of $3.08 on . Cyclacel Pharmaceuticals Inc stock price today i.e. is closed at $6.26,which is 98.95% down from its 52 week high and 103.24% up from its 52 week low.

What is Cyclacel Pharmaceuticals Inc's market capitalisation today?

Cyclacel Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Cyclacel Pharmaceuticals Inc Stock (CYCC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cyclacel Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cyclacel Pharmaceuticals Inc Shares that will get you 0.2396 shares as per Cyclacel Pharmaceuticals Inc share price of $6.26 per share as on September 12, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cyclacel Pharmaceuticals Inc Stock (CYCC) from India?

Indian investors can start investing in Cyclacel Pharmaceuticals Inc (CYCC) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Cyclacel Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cyclacel Pharmaceuticals Inc share’s latest price of $6.26 as on September 12, 2025 at 1:28 am IST, you will get 1.5974 shares of Cyclacel Pharmaceuticals Inc. Learn more about fractional shares .